Business Context and Reporting Period
This Form 8-K Current Report was filed by Eli Lilly and Company on February 10, 2025, regarding an event occurring on that date. The report details the execution of an underwriting agreement for a multi-tranche debt offering.
Key Financial Metrics
The filing discloses the issuance of six new series of senior notes with a total aggregate principal amount of $6.5 billion. Upon closing on February 12, 2025, the Company realized net proceeds of approximately $6.46 billion after underwriting discounts but before estimated offering expenses.
| Note Series | Principal Amount | Coupon Rate | Maturity Date |
|---|---|---|---|
| 2028 Notes | $1.0 billion | 4.550% | February 12, 2028 |
| 2030 Notes | $1.25 billion | 4.750% | February 12, 2030 |
| 2032 Notes | $1.0 billion | 4.900% | February 12, 2032 |
| 2035 Notes | $1.25 billion | 5.100% | February 12, 2035 |
| 2055 Notes | $1.25 billion | 5.500% | February 12, 2055 |
| 2065 Notes | $0.75 billion | 5.600% | February 12, 2065 |
Interest on all notes is payable semi-annually. The filing does not provide updated figures for revenue, profit, cash flow, or existing debt levels outside of this new issuance.
Material Changes
The primary material change is the expansion of the Company's debt capital structure through the addition of $6.5 billion in new long-term liabilities. This transaction increases the Company's total outstanding debt obligations and alters its interest rate profile with coupons ranging from 4.550% to 5.600%.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on operational outlook, or specific risk factors beyond standard debt covenants. Key terms include:
- Redemption: The Company may redeem the notes, in whole or in part, at its election based on redemption prices and terms set forth in the notes.
- Default: Upon an Event of Default, the principal amount of any affected series may be declared immediately due and payable.
- Underwriters: The offering was led by Barclays Capital Inc., BofA Securities, Inc., Citigroup Global Markets Inc., Deutsche Bank Securities Inc., and Goldman Sachs & Co. LLC.
Investor Verification Checklist
- Verify the final net proceeds after deducting estimated offering expenses, as the $6.46 billion figure excludes these costs.
- Review the specific redemption schedules and call protection periods detailed in the Indenture (Exhibit 4.1) and Officers' Certificate (Exhibit 4.3).
- Confirm the impact of this $6.5 billion issuance on the Company's total leverage ratios and liquidity position in subsequent quarterly reports.
- Check for any changes in the Company's credit rating following this issuance.